Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy
Year of publication: |
2021
|
---|---|
Authors: | Alcenat, Stéphane ; Maréchal, François ; Naegelen, Florence |
Published in: |
International journal of health economics and management. - New York, NY : Springer, ISSN 2199-9031, ZDB-ID 2817492-6. - Vol. 21.2021, 1, p. 81-97
|
Subject: | Genetic information | Healthcare | Moral hazard | Optimal contracts | Personalized medicine | Pharmacoeconomics | Moral Hazard | Arzneimittel | Pharmaceuticals | Theorie | Theory | Gesundheitsversorgung | Health care | Prinzipal-Agent-Theorie | Agency theory | Krankenversicherung | Health insurance | Medizinische Behandlung | Medical treatment |
-
Choosing outcomes-based reimbursement policies : should we worry about collusion?
Zorc, Sasa, (2024)
-
Integrated insurance design in the presence of multiple medical technologies
Goldman, Dana P., (2007)
-
Integrated insurance design in the presence of multiple medical technologies
Goldman, Dana P., (2007)
- More ...
-
Tests génétiques prédictifs et marchés de l'assurance santé
Alcenat, Stéphane, (2019)
-
The optimal contract under adverse selection in a moral-hazard model with a risk-averse agent
Maréchal, François, (2018)
-
The impact of medical complications on optimal hospital payment
Maréchal, François, (2021)
- More ...